Please assess the completion status of the following clinical trial:

Trial Title: Epidural and Intravenous Patient-Controlled Analgesia Following Lumbar Spinal Fusion Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult subjects aged 18 years or older~* Scheduled for elective posterior lumbar spinal fusion surgery between 1 and 3 levels~Exclusion Criteria:~* Baseline cognitive deficits sufficient to make objective pain self-assessments unreliable in the estimation of the Study Investigators.~* Immunocompromised subject~* Coagulopathy~* Severe liver and renal dysfunction~* Preoperative neurological deficits~* The dura damage during surgery~* Inability to follow directions or comprehend the English language.~* Females who are pregnant as determined by positive pregnancy test on or before the day of surgery.~* Prisoners.~* Patient refusal to provide informed consent.~* Allergy to amide local anesthetics (lidocaine, bupivacaine, ropivacaine) or opioid (fentanyl) allergy if patient assigned epidural analgesia.~* Hydromorphone allergy if patient assigned IV PCA

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Patient-Controlled Epidural Analgesia (Type: EXPERIMENTAL): Bupivacaine and fentanyl infusion via Continuous Lumbar Epidural Analgesia during postoperative 72 hours
- Intravenous patient-controlled analgesia (Type: SHAM_COMPARATOR): Postoperative intravenous patient-controlled analgesia (IV PCA) with Hydromorphone

Based on this trial design, predict the completion outcome and termination type (if applicable).